Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2005 2
2006 1
2010 2
2012 2
2013 5
2014 2
2015 3
2016 2
2017 12
2018 8
2019 8
2020 5
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.
Hong DS, Fakih MG, Strickler JH, Desai J, Durm GA, Shapiro GI, Falchook GS, Price TJ, Sacher A, Denlinger CS, Bang YJ, Dy GK, Krauss JC, Kuboki Y, Kuo JC, Coveler AL, Park K, Kim TW, Barlesi F, Munster PN, Ramalingam SS, Burns TF, Meric-Bernstam F, Henary H, Ngang J, Ngarmchamnanrith G, Kim J, Houk BE, Canon J, Lipford JR, Friberg G, Lito P, Govindan R, Li BT. Hong DS, et al. Among authors: burns tf. N Engl J Med. 2020 Sep 24;383(13):1207-1217. doi: 10.1056/NEJMoa1917239. Epub 2020 Sep 20. N Engl J Med. 2020. PMID: 32955176 Clinical Trial.
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.
Chatterjee S, Burns TF. Chatterjee S, et al. Among authors: burns tf. Int J Mol Sci. 2017 Sep 15;18(9):1978. doi: 10.3390/ijms18091978. Int J Mol Sci. 2017. PMID: 28914774 Free PMC article. Review.
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Mato AR, Thompson M, Allan JN, Brander DM, Pagel JM, Ujjani CS, Hill BT, Lamanna N, Lansigan F, Jacobs R, Shadman M, Skarbnik AP, Pu JJ, Barr PM, Sehgal AR, Cheson BD, Zent CS, Tuncer HH, Schuster SJ, Pickens PV, Shah NN, Goy A, Winter AM, Garcia C, Kennard K, Isaac K, Dorsey C, Gashonia LM, Singavi AK, Roeker LE, Zelenetz A, Williams A, Howlett C, Weissbrot H, Ali N, Khajavian S, Sitlinger A, Tranchito E, Rhodes J, Felsenfeld J, Bailey N, Patel B, Burns TF, Yacur M, Malhotra M, Svoboda J, Furman RR, Nabhan C. Mato AR, et al. Among authors: burns tf. Haematologica. 2018 Sep;103(9):1511-1517. doi: 10.3324/haematol.2018.193615. Epub 2018 Jun 7. Haematologica. 2018. PMID: 29880613 Free PMC article.
Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer.
Yochum ZA, Cades J, Wang H, Chatterjee S, Simons BW, O'Brien JP, Khetarpal SK, Lemtiri-Chlieh G, Myers KV, Huang EH, Rudin CM, Tran PT, Burns TF. Yochum ZA, et al. Among authors: burns tf. Oncogene. 2019 Jan;38(5):656-670. doi: 10.1038/s41388-018-0482-y. Epub 2018 Aug 31. Oncogene. 2019. PMID: 30171258 Free PMC article.
The next generation of immunotherapy: keeping lung cancer in check.
Somasundaram A, Burns TF. Somasundaram A, et al. Among authors: burns tf. J Hematol Oncol. 2017 Apr 24;10(1):87. doi: 10.1186/s13045-017-0456-5. J Hematol Oncol. 2017. PMID: 28434399 Free PMC article. Review.
Targeting KRAS-Mutant Non-Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations.
Burns TF, Borghaei H, Ramalingam SS, Mok TS, Peters S. Burns TF, et al. J Clin Oncol. 2020 Dec 10;38(35):4208-4218. doi: 10.1200/JCO.20.00744. Epub 2020 Oct 26. J Clin Oncol. 2020. PMID: 33104438 No abstract available.
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics.
Torka P, Kothari SK, Sundaram S, Li S, Medeiros LJ, Ayers EC, Landsburg DJ, Bond DA, Maddocks KJ, Giri A, Hess B, Pham LQ, Advani R, Liu Y, Barta SK, Vose JM, Churnetski MC, Cohen JB, Burkart M, Karmali R, Zurko J, Mehta A, Olszewski AJ, Lee S, Hill BT, Burns TF, Lansigan F, Rabinovich E, Peace D, Groman A, Attwood K, Hernandez-Ilizaliturri FJ. Torka P, et al. Among authors: burns tf. Blood Adv. 2020 Jan 28;4(2):253-262. doi: 10.1182/bloodadvances.2019000875. Blood Adv. 2020. PMID: 31945157 Free PMC article.
Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer.
Gerber DE, Camidge DR, Morgensztern D, Cetnar J, Kelly RJ, Ramalingam SS, Spigel DR, Jeong W, Scaglioni PP, Zhang S, Li M, Weaver DT, Vaikus L, Keegan M, Horobin JC, Burns TF. Gerber DE, et al. Among authors: burns tf. Lung Cancer. 2020 Jan;139:60-67. doi: 10.1016/j.lungcan.2019.10.033. Epub 2019 Nov 4. Lung Cancer. 2020. PMID: 31739184 Free PMC article. Clinical Trial.
The estrogen pathway as a modulator of response to immunotherapy.
Velez MA, Burns TF, Stabile LP. Velez MA, et al. Among authors: burns tf. Immunotherapy. 2019 Sep;11(13):1161-1176. doi: 10.2217/imt-2019-0024. Epub 2019 Jul 30. Immunotherapy. 2019. PMID: 31361169 Review.
Is the game over for PD-1 inhibitors in EGFR mutant non-small cell lung cancer?
Velez MA, Burns TF. Velez MA, et al. Among authors: burns tf. Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S339-S342. doi: 10.21037/tlcr.2019.04.09. Transl Lung Cancer Res. 2019. PMID: 32038910 Free PMC article. No abstract available.
50 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback